Axon Enterprise, Inc $AXON Shares Acquired by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC raised its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 46.0% in the 3rd quarter, Holdings Channel reports. The firm owned 30,432 shares of the biotechnology company’s stock after purchasing an additional 9,582 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in Axon Enterprise were worth $12,858,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AXON. Pure Financial Advisors LLC grew its position in shares of Axon Enterprise by 6.7% in the 4th quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock valued at $207,000 after buying an additional 23 shares during the last quarter. Keel Point LLC increased its stake in shares of Axon Enterprise by 4.4% in the first quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock valued at $254,000 after buying an additional 25 shares during the period. Bridgewater Advisors Inc. increased its stake in shares of Axon Enterprise by 4.4% in the second quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after buying an additional 26 shares during the period. Roman Butler Fullerton & Co. raised its position in shares of Axon Enterprise by 2.4% during the first quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock worth $500,000 after acquiring an additional 30 shares during the last quarter. Finally, 44 Wealth Management LLC raised its position in shares of Axon Enterprise by 6.0% during the first quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock worth $225,000 after acquiring an additional 30 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 9,605 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the sale, the insider owned 97,761 shares in the company, valued at $61,266,818.70. This represents a 8.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 47,397 shares of company stock valued at $26,722,984 over the last 90 days. 4.20% of the stock is owned by company insiders.

Axon Enterprise Price Performance

AXON stock opened at $390.29 on Friday. The firm has a market cap of $31.71 billion, a price-to-earnings ratio of 161.95, a PEG ratio of 7.34 and a beta of 1.44. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02. The company’s fifty day simple moving average is $501.59 and its 200 day simple moving average is $474.43.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter in the prior year, the firm posted $2.12 earnings per share. The business’s quarterly revenue was up 35.3% compared to the same quarter last year. On average, analysts expect that Axon Enterprise, Inc will post 2.12 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts recently commented on AXON shares. Zacks Research raised Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Monday, October 5th. Argus upped their target price on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, September 3rd. Piper Sandler increased their target price on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Morgan Stanley raised their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Finally, UBS Group raised their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $718.47.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.